To test this hypothesis, we generated SLC38A2-deficient tumour cells using single guide RNA (sgRNA) targeting Slc38a2 (sgSlc38a2)—or non-targeting control (sgNTC)—to delete SLC38A2 in Cas9-expressing MC38 cells (Fig. 2g). This evidence concerns the gene SLC38A2 and neoplasm.